Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
AssigneeBeijing Innocare Pharma Tech Co., Ltd.
InventorsXiangyang Chen, Zuopeng WANG, Liqin YU
Life of this patent
Estimating the term…
Abstract
The present invention relates to an amorphous solid dispersion comprises 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide (Compound I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable polymer. The present invention also relates to pharmaceutical compositions comprising the amorphous solid dispersion. The amorphous solid dispersion of the present invention is stable upon storage and provides a better dissolution rate and bioavailability when comparing with a crystalline form.
Claims9
An amorphous solid dispersion comprises compound I or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable polymer,
- wherein the polymer is selected from the group consisting of hydroxypropylmethylcellulose-acetate succinate (HPMC-AS), polyvinylpyrrolidone-vinyl acetate copolymer (PVP-VA), polyvinylpyrrolidone (PVP), and hydroxypropylmethylcellulose (HPMC).
Dependencies are inferred from the claim text.